03.05.2017 20:00:00
|
Diplomat to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference
FLINT, Mich., May 3, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, has announced that Phil Hagerman, CEO and chairman, will present at the upcoming Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas, NV.
Mr. Hagerman is scheduled to present at the conference on Tuesday, May 16, 2017, at 4:20 p.m. P.T. A live audio-only webcast of the presentation and related presentation materials will be available on the investor relations section of the Company's website at ir.diplomat.is. The archived webcast and presentation materials will also be available for approximately 90 days at the same URL.
About Diplomat
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit diplomat.is.
INVESTOR CONTACT:
Bob East, Westwicke Partners
443.213.0500 | diplomat@westwicke.com
MEDIA CONTACT:
Jenny Cretu, Diplomat
810.768.9370 | jcretu@diplomat.is
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diplomat-to-participate-in-bank-of-america-merrill-lynch-2017-healthcare-conference-300450744.html
SOURCE Diplomat Pharmacy, Inc.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Diplomat Pharmacy Incmehr Nachrichten
Keine Nachrichten verfügbar. |